EPITalk: Behind the Paper podcast

Beyond the Hype: Who Can Actually Access GLP-1s?

0:00
26:04
Spol 15 sekunder tilbage
Spol 15 sekunder frem

Send us Fan Mail

Dr. Jenna Sanborn joins EPITalk: Behind the Paper to discuss the GLP-1 access gap and her newly published research article, “GLP-1 receptor agonist medications for weight loss: Sociodemographic patterns of awareness, use, and access in a U.S. national cohort,” published in the October 2026 (Vol. 122) issue of Annals of Epidemiology. This study aimed to describe patterns of glucagon-like peptide-1 receptor agonist (GLP1-RA) medication awareness, use, and access in a US adult cohort.

Read the full article here:
https://www.sciencedirect.com/science/article/pii/S1047279726001493

Episode Credits:

  • Executive Producer: Sabrina Debas (Episodes 1-18) and Sofina Tran (19-)
  • Technical Producer: Paula Burrows
  • Annals of Epidemiology is published by Elsevier



Flere episoder fra "EPITalk: Behind the Paper"